General factors
Early onset of urolithiasis (especially children and teenagers)
Familial stone formation
Brushite-containing stones (CaHPO4.2H2O)
Uric acid and urate-containing stones
Infection stones
Solitary kidney (the kidney itself does not particularly increase the risk of stone formation, but prevention
Diseases associated with stone formation
Hyperparathyroidism
Metabolic syndrome
Nephrocalcinosis
Gastrointestinal diseases (i.e., jejuno-ileal bypass, intestinal resection, Crohn’s disease, malabsorptive conditions, enteric hyperoxaluria after urinary diversion) and bariatric surgery
Sarcoidosis
Genetically determined stone formation
Cystinuria (type A, B and AB)
Primary hyperoxaluria
Xanthinuria
Renal tubular acidosis (RTA) type I
2,8-Dihydroxyadeninuria
Lesch-Nyhan syndrome
Cystic fibrosis
Anatomical abnormalities associated with stone formation
Medullary sponge kidney (tubular ectasia)
Ureteropelvic junction (UPJ) obstruction
Calyceal diverticulum, calyceal cyst
Ureteral stricture
Vesico-uretero-renal reflux
Horseshoe kidney
Ureterocele
Drugs associated with stone formation
Active compounds crystallizing in urine
Allopurinol/oxypurinol, Amoxicillin/ampicillin, Ceftriaxone, Quinolones, Ephedrine Indinavir, Magnesium trisilicate, Sulphonamides, Triamterene, Zonisamide
Substances impairing urine composition
Acetazolamide, Allopurino, Aluminum magnesium hydroxide, Ascorbic acid, Calcium, Furosemide, Laxatives, Methoxyflurane, Vitamin D, Topiramate
Selection of Patients for Metabolic Evaluation
Nowadays there is still a debate which patient requires metabolic evaluation. One helpful consideration could be the stratification of patient to low and high risk of recurrence. For routine every day practice abbreviated protocol for low-risk single stone formers may be applied in stone formers evaluated without increases risk of recurrence [2, 3] (Table 24.2). A comprehensive evaluation is mandatory in patient who present with episodes of recurrence and are evaluated as stone formers at high risk. Historically extensive metabolic evaluation included fast and calcium loaded tests in order to discriminate between various forms of hyperoxaluria. In every day setting routine performance of calcium fast/load test is not required t complete metabolic evaluation (Table 24.3). Most urologists would perform specific metabolic evaluation of collection of two consecutive 24-h urine samples [4, 7]. For the initial specific metabolic work-up, the patient should stay on a self-determined diet under the conditions of everyday lifestyle. Follow-up should be performed at 6–12 weeks after the initiation of treatment regimen for stone recurrence.
Table 24.2
Abbreviated protocol for low-risk single stone formers
Low-risk single stone formers | |
---|---|
Medical history Information on dietary habits and social history Blood investigations Urine investigations Imaging Stone analyses | Rule out bowel disease, chronic diarrhea, Crohn, (enteric hyperoxaluria), gout (hyperuricosuria), leading to calcium oxalate or uric acid stone formation
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |